Meddena - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 646,142 | 690,972 | 416,367 | 737,319 | 798,297 | 868,707 | 840,902 | 815,084 |
| Profit before tax | 229,770 | 240,503 | 126,438 | 296,050 | 313,775 | 377,393 | 338,569 | 340,725 |
| Net profit | 195,507 | 204,428 | 107,472 | 251,642 | 266,709 | 320,784 | 287,784 | 286,209 |
| Equity | 202,347 | 207,157 | 123,780 | 254,680 | 270,785 | 324,255 | 291,720 | 289,319 |
| Liabilities | 78,093 | 72,004 | 51,211 | 61,351 | 33,146 | 34,037 | 4,440 | 6,290 |
| Non-current assets | 30,529 | 33,163 | 28,074 | 22,571 | 31,331 | 24,243 | 14,384 | 6,964 |
| Current assets | 249,911 | 245,998 | 146,917 | 293,460 | 272,600 | 334,049 | 281,776 | 288,645 |
| Total assets | 280,440 | 279,161 | 174,991 | 316,031 | 303,931 | 358,292 | 296,160 | 295,609 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 172,823 | 193,449 | 163,612 |
| Social insurance contributions | - | - | - | - | - | 17,246 | 22,791 | 23,952 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -2.1% | +6.9% | -39.7% | +77.1% | +8.3% | +8.8% | -3.2% | -3.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 69.7% | 73.2% | 61.4% | 79.6% | 87.8% | 89.5% | 97.2% | 96.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 96.6% | 98.7% | 86.8% | 98.8% | 98.5% | 98.9% | 98.7% | 98.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 30.3% | 29.6% | 25.8% | 34.1% | 33.4% | 36.9% | 34.2% | 35.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 35.6% | 34.8% | 30.4% | 40.2% | 39.3% | 43.4% | 40.3% | 41.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.3 | 0.4 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 129,228 | 140,536 | 83,273 | 138,248 | 140,875 | 173,741 | 168,180 | 163,017 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Meddena - Social security debts
The company had no debts to Sodra
Meddena - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Meddena is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-08-28 | 2026-09-02 | 0.06 |
| 2026-01-01 | 2026-01-12 | 3.22 |
| 2025-12-18 | 2025-12-23 | 3.22 |
| 2025-12-01 | 2025-12-09 | 0.84 |
| 2025-11-02 | 2025-11-30 | 2.24 |
| 2025-07-31 | 2025-08-11 | 3.43 |
| 2025-07-28 | 2025-07-30 | 3.54 |
| 2025-06-28 | 2025-07-24 | 3.54 |
| 2025-06-19 | 2025-06-25 | 3.54 |
| 2025-05-08 | 2025-05-08 | 946.97 |
| 2025-04-28 | 2025-05-07 | 2.97 |
| 2025-03-28 | 2025-04-23 | 2.97 |
| 2025-03-20 | 2025-03-24 | 2.97 |
| 2025-02-20 | 2025-02-25 | 2.97 |
| 2024-12-30 | 2025-01-27 | 2.97 |
| 2024-12-19 | 2024-12-23 | 2.97 |
| 2024-12-01 | 2024-12-11 | 2.97 |
| 2024-11-28 | 2024-11-30 | 4.86 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Meddena, UAB (code 135444247) is a private limited liability company operating in the wholesale of pharmaceutical and medical goods. In 2025, revenue amounted to €815.1K, down 3.1% year on year and 6.2% below the 2023 level. Net profit in 2025 was €286.2K, compared with €287.8K in 2024 and €320.8K in 2023, while the profit margin remained solid at 35.1% after 34.2% in 2024 and 36.9% in 2023. The balance sheet was small and conservative, with total assets of €295.6K, equity of €289.3K and liabilities of €6.3K at the end of 2025. The equity ratio stood at 97.9% and debt-to-equity at 0.02, pointing to very low leverage. Asset turnover was 2.76x. Profitability remained strong relative to the company’s asset base. Revenue per employee reached €163.0K and profit per employee €57.2K in 2025.